This project utilizes intratracheal instillation and breathing aerosols to deliver a variety of molecules, mediators, and drugs to the lungs of animals. Two parallel specific aims are proposed. In the first, we will answer key questions relating to how these delivery methods produce measured patterns of delivery to specified anatomic regions. We will also explore how the aerosolization process alters the proteins or carriers. In the second, we will apply these methods of drug delivery to animals with Pneumocystis carinii or cytomegalovirus infection.
Our specific aims are: 1. To improve pulmonary delivery of proteins and other therapeutic agents via the airways. This research will include: a. Analysis of instillation as a prelude and/or an alternative to aerosol delivery. b. Analysis of how aerosolization affects proteins and carriers. c. Analysis of the distribution and morphologic fate of deposited proteins in the lung. 2. To apply the above strategies to existing models of opportunistic lung infection. This research will include the following: a. Evaluation of potential upregulators of host defenses against Pneumocystis carinii. b. Evaluation of instillation vs. aerosol inhalation and the role of surfactant on spreading of drugs in the treatment of Pneumocystis carinii. c. Evaluation of instilled and aerosolized antiviral compounds (both a standard drug, ganciclovir, and novel antisense oligonucleotides) in relation to a murine CMV model. The proposed research will test key hypotheses central to the entire program. For example, the ability of IL-13 to upregulate the mannose receptor on lung macrophages and thus to enhance the clearance of Pneumocystis carinii from the lungs will be evaluated, a goal relevant to Project 0007. The potential of antisense oligonucleotides to treat cytomegalovirus infection will be tested, a goal relevant to Project 0010. We seek to develop data on how these and other molecules deposit and distribute within the lungs how they critically affect host defenses and how, in turn, that affects the fate of lung pathogens. The immediate goal is excellent science; the ultimate goal is new therapeutic strategies for opportunistic lung infections for human with AIDS.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL043510-07
Application #
3736788
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
Saukkonen, Jussi J; Bazydlo, Beth; Thomas, Michael et al. (2002) Beta-chemokines are induced by Mycobacterium tuberculosis and inhibit its growth. Infect Immun 70:1684-93
Ghosh, S; Frisardi, M; Rogers, R et al. (2001) How Giardia swim and divide. Infect Immun 69:7866-72
Yang, Y M; Hatch, W C; Liu, Z Y et al. (2001) Beta-chemokine induction of activation protein-1 and cyclic AMP responsive element activation in human myeloid cells. Cell Growth Differ 12:211-21
Stehle, S E; Rogers, R A; Harmsen, A G et al. (2000) A soluble mannose receptor immunoadhesin enhances phagocytosis of Pneumocystis carinii by human polymorphonuclear leukocytes in vitro. Scand J Immunol 52:131-7
Venkatakrishnan, G; Salgia, R; Groopman, J E (2000) Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells. J Biol Chem 275:6868-75
Koziel, H; Li, X; Armstrong, M Y et al. (2000) Alveolar macrophages from human immunodeficiency virus-infected persons demonstrate impaired oxidative burst response to Pneumocystis carinii in vitro. Am J Respir Cell Mol Biol 23:452-9
Trujillo, J R; Goletiani, N V; Bosch, I et al. (2000) T-tropic sequence of the V3 loop is critical for HIV-1 infection of CXCR4-positive colonic HT-29 epithelial cells. J Acquir Immune Defic Syndr 25:10-Jan
Rees, D D; Rogers, R A; Cooley, J et al. (1999) Recombinant human Monocyte/Neutrophil elastase inhibitor protects rat lungs against injury from cystic fibrosis airway secretions. Am J Respir Cell Mol Biol 20:69-78
Park, I W; Wang, J F; Groopman, J E (1999) Expression and utilization of co-receptors in HIV and simian immunodeficiency virus infection of megakaryocytes. AIDS 13:2023-32
Koziel, H; Kim, S; Reardon, C et al. (1999) Enhanced in vivo human immunodeficiency virus-1 replication in the lungs of human immunodeficiency virus-infected persons with Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 160:2048-55

Showing the most recent 10 out of 98 publications